Henoch-Schölein purpura and polysaccharide meningococcal vaccine

Pediatrics
Michael J GoodmanJames Baggs

Abstract

We describe here a case of Henoch-Schönlein purpura (HSP) that occurred 10 days after administration of the meningococcal polysaccharide vaccine and came to the attention of a Vaccine Safety Datalink (VSD) investigator (but did not occur in the VSD cohort). Periodic case reports have linked vaccines to HSP. To better understand the potential risk for HSP after immunization with the meningococcal polysaccharide vaccine. We studied the VSD cohort to estimate the 42-day postvaccination incidence rate of HSP in the VSD population 16 to 20 years of age. Electronic data from all 8 VSD sites were gathered. All subjects aged 16 to 20 years who received a meningococcal polysaccharide vaccine were followed for 42 days after that vaccination for evidence of HSP. Background rates were determined by examining all the nonexposed time of the same cohort. No cases of HSP were seen in the 42 days after 49,027 doses of meningococcal polysaccharide vaccine among the entire VSD adolescent and young adult population. The background incidence rate was 4.2 per 100,000 person-years. These data provide the strongest evidence so far that HSP is not associated with receipt of meningococcal polysaccharide vaccine in the 16- to 20-year age group.

Citations

Jul 4, 2013·Nature Reviews. Rheumatology·Clovis A SilvaEloisa Bonfa
Jan 16, 2013·Current Opinion in Rheumatology·Maryam Piram, Alfred Mahr
Apr 6, 2013·Expert Review of Clinical Immunology·Olga Vera-LastraYehuda Shoenfeld
Jul 9, 2011·Advances in Pediatrics·Ayesha Mirza, Mobeen H Rathore
Sep 24, 2015·Vaccine·Caterina BonettoUNKNOWN Brighton Collaboration Vasculitis Working Group
Aug 16, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Luísa Eça GuimarãesYehuda Shoenfeld
Aug 12, 2014·Vaccine·Michael M McNeilFrank DeStefano
Jun 19, 2016·Italian Journal of Pediatrics·Liviana Da DaltUNKNOWN Italian Multicenter Study Group for Drug and Vaccine Safety in Children
Apr 21, 2011·Lupus·R Cervera
Aug 25, 2017·Clinical Reviews in Allergy & Immunology·Sebastiano A G LavaMario G Bianchetti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.